pSivida Corp VP Unloads $47,034 in Stock (PSDV)
pSivida Corp (NASDAQ:PSDV) VP Lori Freedman sold 11,700 shares of the stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $4.02, for a total value of $47,034.00. Following the completion of the sale, the vice president now directly owns 96,423 shares in the company, valued at approximately $387,620. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of pSivida Corp (NASDAQ:PSDV) traded down 0.25% on Tuesday, hitting $4.00. The stock had a trading volume of 54,499 shares. pSivida Corp has a 1-year low of $2.28 and a 1-year high of $5.60. The stock’s 50-day moving average is $3.72 and its 200-day moving average is $3.94. The company’s market cap is $117.0 million.
pSivida Corp (NASDAQ:PSDV) last released its earnings data on Tuesday, May 13th. The company reported ($0.03) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.15) by $0.12. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $0.55 million. On average, analysts predict that pSivida Corp will post $-0.69 earnings per share for the current fiscal year.
Separately, analysts at MLV & Co
initiated coverage on shares of pSivida Corp in a research note on Monday, May 5th. They set a “buy” rating and a $6.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. pSivida Corp currently has a consensus rating of “Buy” and a consensus price target of $5.43.
pSivida Corp. develops drug delivery products that are administered by implantation, injection or insertion.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.